Explore more publications!
French Industry Network
Got News to Share?

French Industry Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 9, 2026

Fera Science Ltd (Fera) Strengthens Its Laboratory Assurance Services with The Acquisition of Qotho Minerals
Mar. 9, 2026

Fera Science Ltd (Fera) Strengthens Its Laboratory Assurance Services with The Acquisition of Qotho Minerals

Indeterminate EIN Presswire
MASAI UJIRI AND GIANTS OF AFRICA EXPAND BUILT WITHIN COMMUNITY BASKETBALL COURT INITIATIVE INTO THE SAHEL REGION
Mar. 9, 2026

MASAI UJIRI AND GIANTS OF AFRICA EXPAND BUILT WITHIN COMMUNITY BASKETBALL COURT INITIATIVE INTO THE SAHEL REGION

Indeterminate EIN Presswire
VALLOUREC ÉQUIPE LA PREMIÈRE INSTALLATION CALIFORNIENNE DE CAPTURE ET DE STOCKAGE DE CARBONE AVEC SES SOLUTIONS TUBULAIRES DE POINTE
Mar. 9, 2026

VALLOUREC ÉQUIPE LA PREMIÈRE INSTALLATION CALIFORNIENNE DE CAPTURE ET DE STOCKAGE DE CARBONE AVEC SES SOLUTIONS TUBULAIRES DE POINTE

Indeterminate GlobeNewswire
VALLOUREC POWERS CALIFORNIA’S FIRST CARBON CAPTURE AND STORAGE FACILITY WITH ITS ADVANCED TUBULAR SOLUTIONS
Mar. 9, 2026

VALLOUREC POWERS CALIFORNIA’S FIRST CARBON CAPTURE AND STORAGE FACILITY WITH ITS ADVANCED TUBULAR SOLUTIONS

Indeterminate GlobeNewswire
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF    
Mar. 9, 2026

GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF    

Indeterminate GlobeNewswire
GENFIT reçoit la désignation Orphan Drug de la FDA pour NTZ dans le traitement de l’ACLF
Mar. 9, 2026

GENFIT reçoit la désignation Orphan Drug de la FDA pour NTZ dans le traitement de l’ACLF

Indeterminate GlobeNewswire
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026 
Mar. 9, 2026

Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026 

Indeterminate GlobeNewswire
Valneva publiera ses résultats financiers consolidés 2025 le 18 mars 2026
Mar. 9, 2026

Valneva publiera ses résultats financiers consolidés 2025 le 18 mars 2026

Indeterminate GlobeNewswire
Esker Launches New Quote Request Solution to Simplify Everyday Sourcing
Mar. 9, 2026

Esker Launches New Quote Request Solution to Simplify Everyday Sourcing

Indeterminate GlobeNewswire
kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics
Mar. 9, 2026

kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics

Indeterminate GlobeNewswire
Sodexo celebrates its 60th anniversary
Mar. 9, 2026

Sodexo celebrates its 60th anniversary

Indeterminate GlobeNewswire
Sodexo célèbre ses 60 ans
Mar. 9, 2026

Sodexo célèbre ses 60 ans

Indeterminate GlobeNewswire
Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
Mar. 9, 2026

Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma

Indeterminate GlobeNewswire
Ipsen retire volontairement Tazverik® (tazemetostat) dans le traitement du lymphome folliculaire et du sarcome épithélioïde
Mar. 9, 2026

Ipsen retire volontairement Tazverik® (tazemetostat) dans le traitement du lymphome folliculaire et du sarcome épithélioïde

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions